Skip to main content
. 2024 May 6;16(2):283–294. doi: 10.3390/hematolrep16020028

Figure 2.

Figure 2

All-Cause Mortality at 6 and 12 Months and End of Follow-Up Since aGVHD Development. aGVHD, acute graft-versus-host disease.